This report contains market size and forecasts of OX40 Receptor Agonist in global, including the following market information:
Global OX40 Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global OX40 Receptor Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five OX40 Receptor Agonist companies in 2021 (%)
The global OX40 Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fully Human IgG2 Agonist Ab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of OX40 Receptor Agonist include Merk, Pfizer, GlaxoSmithKline, Glenmark, AstraZeneca (MedImmune), Roche, Agenus, Bristol Myers Squibb and Bioinvent, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OX40 Receptor Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OX40 Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global OX40 Receptor Agonist Market Segment Percentages, by Type, 2021 (%)
Fully Human IgG2 Agonist Ab
Humanised IgG1 Agonist mAb
Fully Human IgG1 Agonist mAb
Global OX40 Receptor Agonist Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global OX40 Receptor Agonist Market Segment Percentages, by Application, 2021 (%)
Cancers
Myasthenia Gravis
Psoriasis
Global OX40 Receptor Agonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global OX40 Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OX40 Receptor Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies OX40 Receptor Agonist revenues share in global market, 2021 (%)
Key companies OX40 Receptor Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies OX40 Receptor Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merk
Pfizer
GlaxoSmithKline
Glenmark
AstraZeneca (MedImmune)
Roche
Agenus
Bristol Myers Squibb
Bioinvent
Sorrento Therapeutics
Incyte